Cyclin D1 Antikörper
-
- Target Alle Cyclin D1 (CCND1) Antikörper anzeigen
- Cyclin D1 (CCND1)
-
Reaktivität
- Human, Affe, Fledermaus
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser Cyclin D1 Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB), Immunohistochemistry (IHC), Flow Cytometry (FACS), Immunoprecipitation (IP), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))
- Spezifität
- Human Cyclin D1
- Aufreinigung
- Affinity purified
- Immunogen
-
Human Cyclin D1 C-terminal synthetic peptide (EEEEEVDLACTPTDVRDVDI).
Type of Immunogen: Synthetic peptide - Isotyp
- IgG
- Top Product
- Discover our top product CCND1 Primärantikörper
-
-
- Applikationshinweise
-
Approved: Flo (10 μg/mL), IHC, IHC-P (1 - 10 μg/mL), IP, WB (0.1 - 1 μg/mL)
Usage: IHC: Heat treatment is necessary for paraffin-embedded sections,IP: 1 μg/300 μL of cell extract from 5x106 cells, - Kommentare
-
Target Species of Antibody: Human
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Konzentration
- Lot specific
- Buffer
- PBS, pH 7.2, 50 % glycerol
- Lagerung
- -20 °C
- Informationen zur Lagerung
- Store at -20°C.
-
- Target
- Cyclin D1 (CCND1)
- Andere Bezeichnung
- CCND1 / Cyclin D1 (CCND1 Produkte)
- Hintergrund
-
Name/Gene ID: CCND1
Synonyms: CCND1, B-cell lymphoma 1 protein, BCL-1 oncogene, B-cell CLL/lymphoma 1, BCL-1, Cyclin D1, G1/S-specific cyclin-D1, U21B31, PRAD1, BCL1, D11S287E, PRAD1 oncogene - Gen-ID
- 595
- Pathways
- PI3K-Akt Signalweg, Zellzyklus, Mitotic G1-G1/S Phases, ER-Nucleus Signaling
-